Irisin, A Fascinating and Multifunctional Protein: Implication for Health
Abstract
BACKGROUND: Fibronectin type III domain-containing protein 5 (FNDC5), or also known as irisin, has been identified for two decades but almost completely disregarded for 10 years. It is present in skeletal muscle, heart, and brain, and in reaction to exercise can transform white adipose tissue into brown. Since then, irisin has gained a lot of attention for its potencies in treating metabolic disorders. In this review article, the potential future of irisin especially on metabolism and aging process will be discussed.
CONTENT: Sedentary lifestyle is acknowledged as risk factor for type 2 diabetes mellitus, obesity, immune system issues, asthma, and neurological or heart illness. Irisin is secreted by muscle cells when exercising, produced after the proteolytic cleavage of FNDC5 protein. Irisin has positive impacts on maintaining physiological balance including reducing inflammation, keeping the bone homeostasis, as well as influencing metabolic processes and the neurological system function. Due to these many and advantageous characteristics, irisin could be a possible choice for preventing and managing disorders associated with modern society, and finding the agents to increase irisin can be beneficial.
SUMMARY: Irisin offers a fresh potential basis for kinesitherapy and shows promise as a therapeutic target due to its various biological activities. Irisin pathway can be activated through dietary changes, the use of natural substances and drugs and can interact with this signalling pathway which involved peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) and uncoupling protein mRNA 1 (UCP1) to resolve obesity and its metabolic comorbidities.
KEYWORDS: irisin, FNDC5, exercise, inflammation, obesity, nervous system
Full Text:
PDFReferences
Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013; 18(5): 649-59, CrossRef.
Bao JF, She QY, Hu PP, Jia N, Li A. Irisin, a fascinating field in our times. Trends Endocrinol Metab. 2022; 33(9): 601-13, CrossRef.
Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM, et al. Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 2014; 16(8): 711-8, CrossRef.
Chen JQ, Huang YY, Gusdon AM, Qu S. Irisin: A new molecular marker and target in metabolic disorder. Lipids Health Dis. 2015; 14(1): 2, CrossRef.
Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014; 63(2): 514-25, CrossRef.
Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382): 463-8, CrossRef.
Rodríguez A, Becerril S, Ezquerro S, Méndez-Giménez L, Frühbeck G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol. 2017; 219(2): 362-81, CrossRef.
Askari H, Rajani SF, Poorebrahim M, Haghi-Aminjan H, Raeis-Abdollahi E, Abdollahi M. A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: An introductory review. Pharmacol Res. 2018; 129: 44-55, CrossRef.
Nie Y, Dai B, Guo X, Liu D. Cleavage of FNDC5 and insights into its maturation process. Mol Cell Endocrinol. 2020; 510: 110840, CrossRef.
Yu Q, Kou W, Xu X, Zhou S, Luan P, Xu X, et al. FNDC5/irisin inhibits pathological cardiac hypertrophy. Clin Sci. 2019; 133(5): 611-27, CrossRef.
Tsuchiya Y, Mizuno S, Goto K. Irisin response to downhill running exercise in humans. J Exerc Nutrition Biochem. 2018; 22(2): 12-7, CrossRef.
Aydin S, Kuloglu T, Aydin S, Eren MN, Celik A, Yilmaz M, et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: Cardiac muscle produces more irisin than skeletal muscle. Peptides. 2014; 52: 68-73, CrossRef.
Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012; 61(12): 1725-38, CrossRef.
Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017; 13(6): 324-37, CrossRef.
Flori L, Testai L, Calderone V. The “irisin system”: From biological roles to pharmacological and nutraceutical perspectives. Life Sci. 2021; 267: 118954, CrossRef.
Reycraft JT, Islam H, Townsend LK, Hayward GC, Hazell TOMJ, MacPherson REK. Exercise intensity and recovery on circulating brain-derived neurotrophic factor. Med Sci Sports Exerc. 2020; 52(5): 1210-7, CrossRef.
Ozbay S, Ulupinar S, Şebin E, Altinkaynak K. Acute and chronic effects of aerobic exercise on serum irisin, adropin, and cholesterol levels in the winter season: Indoor training versus outdoor training. Chin J Physiol. 2020; 63(1): 21-6, CrossRef.
Qiu S, Bosnyák E, Treff G, Steinacker JM, Nieß AM, Krüger K, et al. Acute exercise‐induced irisin release in healthy adults: Associations with training status and exercise mode. Eur J Sport Sci. 2018; 18(9): 1226-33, CrossRef.
Fatouros IG. Is irisin the new player in exercise-induced adaptations or not? A 2017 update. Clin Chem Lab Med. 2018; 56(4): 525-48, CrossRef.
Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014; 281(3): 739-49, CrossRef.
Nygaard H, Slettaløkken G, Vegge G, Hollan I, Whist JE, Strand T, et al. Irisin in blood increases transiently after single sessions of intense endurance exercise and heavy strength training. PLoS One. 2015; 10(3): e0121367, CrossRef.
Eaton M, Granata C, Barry J, Safdar A, Bishop D, Little JP. Impact of a single bout of high-intensity interval exercise and short-term interval training on interleukin-6, FNDC5, and METRNL mRNA expression in human skeletal muscle. J Sport Health Sci. 2018; 7(2): 191-6, CrossRef.
Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pöllänen E, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol. 2013; 591(21): 5393-400, CrossRef.
Parada-Sánchez S, Macias-Cervantes M, Pérez-Vázquez V, Vargas-Ortiz K. The effects of different types of exercise on circulating irisin levels in healthy individuals and in people with overweight, metabolic syndrome and type 2 diabetes. Physiol Res. 2022; 71(4): 457-75, CrossRef.
Huh JY, Siopi A, Mougios V, Park KH, Mantzoros CS. Irisin in response to exercise in humans with and without metabolic syndrome. J Clin Endocrinol Metab. 2015; 100(3): E453-7, CrossRef.
Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeiras AB, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013; 8(4): e60563, CrossRef.
Uysal N, Yuksel O, Kizildag S, Yuce Z, Gumus H, Karakilic A, et al. Regular aerobic exercise correlates with reduced anxiety and incresed levels of irisin in brain and white adipose tissue. Neurosci Lett. 2018; 676: 92-7, CrossRef.
Nie Y, Liu D. N-glycosylation is required for FDNC5 stabilization and irisin secretion. Biochem J. 2017; 474(18): 3167-77, CrossRef.
Tan NY, Bailey UM, Jamaluddin MF, Mahmud SHB, Raman SC, Schulz BL. Sequence-based protein stabilization in the absence of glycosylation. Nat Commun. 2014; 5: 3099, CrossRef.
Schumacher MA, Chinnam N, Ohashi T, Shah RS, Erickson HP. The structure of irisin reveals a novel intersubunit β-sheet fibronectin type III (FNIII) dimer: Implications for receptor activation. J Biol Chem. 2013; 288(47): 33738-44, CrossRef.
Korta P, Pocheć E, Mazur-Biały A. Irisin as a multifunctional protein: Implications for health and certain diseases. Medicina. 2019; 55(8): 485, CrossRef.
Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM, et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 2015; 22(4): 734-40, CrossRef.
Rabiee F, Lachinani L, Ghaedi S, Nasr-Esfahani MH, Megraw TL, Ghaedi K. New insights into the cellular activities of Fndc5/Irisin and its signaling pathways. Cell Biosci. 2020; 10: 51. doi: 10.1186/s13578-020-00413-3, CrossRef.
Hosseini Farahabadi SS, Ghaedi K, Ghazvini Zadegan F, Karbalaie K, Rabiee F, Nematollahi M, et al. ERK1/2 is a key regulator of Fndc5 and PGC1α expression during neural differentiation of mESCs. Neuroscience. 2015; 297: 252-61, CrossRef.
Moon HS, Dincer F, Mantzoros CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism. 2013; 62(8): 1131-6, CrossRef.
Crunkhorn S. Betatrophin boosts β-cells. Nat Rev Drug Discov. 2013; 12(7): 504-5, CrossRef.
Huh JY, Dincer F, Mesfum E, Mantzoros CS. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes. 2014; 38(12): 1538-44, CrossRef.
Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006; 7(12): 885-96, CrossRef.
Pukajło K, Kolackov K, Łaczmański Ł, Daroszewski J. Irisin – A new mediator of energy homeostasis. Postepy Hig Med Dosw. 2015; 69: 233-42, CrossRef.
Whitham M, Febbraio MA. The ever-expanding myokinome: Discovery challenges and therapeutic implications. Nat Rev Drug Discov. 2016; 15(10): 719-29, CrossRef.
Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014; 159(4): 738-49, CrossRef.
Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose uptake — Regulation and implications for glycaemic control. Nat Rev Endocrinol. 2017; 13(3): 133-48, CrossRef.
Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013; 17(2): 162-84, CrossRef.
Takimoto M, Hamada T. Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins. J Appl Physiol. 2014; 116(9): 1238-50, CrossRef.
Bergersen LH. Lactate transport and signaling in the brain: Potential therapeutic targets and roles in body-brain interaction. J Cereb Blood Flow Metab. 2015; 35(2): 176-85, CrossRef.
Newman JC, Verdin E. β-hydroxybutyrate: A signaling metabolite. Annu Rev Nutr. 2017: 37: 51-76, CrossRef.
Światkiewicz M, Fiedorowicz M, Orzeł J, Wełniak-Kamińska M, Bogorodzki P, Langfort J, et al. Increases in brain 1H-MR glutamine and glutamate signals following acute exhaustive endurance exercise in the rat. Front Physiol. 2017; 8: 19, CrossRef.
Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr. 2009; 90(3): 867S-874S, CrossRef.
Matsui T, Omuro H, Liu YF, Soya M, Shima T, Mcewen BS, et al. Astrocytic glycogen-derived lactate fuels the brain during exhaustive exercise to maintain endurance capacity. Proc Natl Acad Sci USA. 2017; 114(24): 6358-63, CrossRef.
Moreno M, Moreno-Navarrete JM, Serrano M, Ortega F, Delgado E, Sanchez-Ragnarsson C, et al. Circulating irisin levels are positively associated with metabolic risk factors in sedentary subjects. PLoS One. 2015; 10(4): e0124100, CrossRef.
Tsuchiya Y, Ando D, Goto K, Kiuchi M, Yamakita M, Koyama K. High-intensity exercise causes greater irisin response compared with low-intensity exercise under similar energy consumption. Tohoku J Exp Med. 2014; 233(2): 135-40, CrossRef.
Tsuchiya Y, Ando D, Takamatsu K, Goto K. Resistance exercise induces a greater irisin response than endurance exercise. Metabolism. 2015; 64(9): 1042-50, CrossRef.
Greulich T, Nell C, Koepke J, Fechtel J, Franke M, Schmeck B, et al. Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - A randomized clinical trial. BMC Pulm Med. 2014; 14: 60, CrossRef.
Varela-Rodríguez BM, Pena-Bello L, Juiz-Valiña P, Vidal-Bretal B, Cordido F, Sangiao-Alvarellos S. FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle. Sci Rep. 2016; 6: 29898, CrossRef.
Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, Nagano K, et al. Irisin mediates effects on bone and fat via αV integrin receptors. Cell. 2018; 175(7): 1756-68.e17, CrossRef.
A M, Wales TE, Zhou H, Draga-Coletă SV, Gorgulla C, Blackmore KA, et al. Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90α. Mol Cell. 2023; 83(11): 1903-20.e12, CrossRef.
Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007; 8(5): 215, CrossRef.
Park EJ, Myint PK, Ito A, Appiah MG, Darkwah S, Kawamoto E, et al. Integrin-ligand interactions in inflammation, cancer, and metabolic disease: Insights into the multifaceted roles of an emerging ligand irisin. Front Cell Dev Biol. 2020; 8: 588066, CrossRef.
Silveira LS, Antunes Bde M, Minari AL, Dos Santos RV, Neto JC, Lira FS. Macrophage polarization: Implications on metabolic diseases and the role of exercise. Crit Rev Eukaryot Gene Expr. 2016; 26(2): 115-32, CrossRef.
Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011; 11(9): 607-15, CrossRef.
Oishi Y, Manabe I. Macrophages in inflammation, repair and regeneration. Int Immunol. 2018; 30(11): 511-28, CrossRef.
Shaw DM, Merien F, Braakhuis A, Dulson D. T-cells and their cytokine production: The anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine. 2018; 104: 136-42, CrossRef.
Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Medicine. 2012; 31(2): 115-44, CrossRef.
Allen J, Sun Y, Woods JA. Exercise and the regulation of inflammatory responses. Prog Mol Biol Transl Sci. 2015; 135: 337-54, CrossRef.
Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016; 83(1): 37-42, CrossRef.
Marqués-Jiménez D, Calleja-González J, Arratibel I, Delextrat A, Terrados N. Are compression garments effective for the recovery of exercise-induced muscle damage? A systematic review with meta-analysis. Physiol Behav. 2016; 153: 133-48, CrossRef.
Delezie J, Handschin C. Endocrine crosstalk between skeletal muscle and the brain. Front Neurol. 2018; 9: 698, CrossRef.
Moonen MPB, Nascimento EBM, van Marken Lichtenbelt WD. Human brown adipose tissue: Underestimated target in metabolic disease? Biochim Biophys Acta Mol Cell Biol Lipids. 2019; 1864(1): 104-12, CrossRef.
Schulz TJ, Tseng YH. Brown adipose tissue: Development, metabolism and beyond. Biochem J. 2013; 453(2): 167-78, CrossRef.
Lidell ME, Betz MJ, Enerbäck S. Brown adipose tissue and its therapeutic potential. J Intern Med. 2014; 276(4): 364-77, CrossRef.
Gouveia MC, Vella JP, Cafeo FR, Affonso Fonseca FL, Bacci MR. Association between irisin and major chronic diseases: A review. Eur Rev Med Pharmacol Sci. 2016; 20(19): 4072-7, PMID.
Wrann CD. FNDC5/irisin - Their role in the nervous system and as a mediator for beneficial effects of exercise on the brain. Brain Plast. 2015; 1(1): 55-61, CrossRef.
So JH, Huang C, Ge M, Cai G, Zhang L, Lu Y, et al. Intense exercise promotes adult hippocampal neurogenesis but not spatial discrimination. Front Cell Neurosci. 2017; 11: 13, CrossRef.
Dun SL, Lyu RM, Chen YH, Chang JK, Luo JJ, Dun NJ. Irisin-immunoreactivity in neural and non-neural cells of the rodent. Neuroscience. 2013; 240: 155-62, CrossRef.
Hashemi MS, Ghaedi K, Salamian A, Karbalaie K, Emadi-Baygi M, Tanhaei S, et al. Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience. 2013; 231: 296-304, CrossRef.
Li DJ, Li YH, Yuan HB, Qu LF, Wang P. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism. 2017; 68: 31-42, CrossRef.
Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci USA. 2015; 112(39): 12157-62, CrossRef.
Qiao XY, Nie Y, Ma YX, Chen Y, Cheng R, Yin WY, et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016; 6: 18732, CrossRef.
Sahin-Efe A, Upadhyay J, Ko BJ, Dincer F, Park KH, Migdal A, et al. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study. Metabolism. 2018; 79: 24-32, CrossRef.
Crujeiras AB, Zulet MA, Lopez-Legarrea P, De La Iglesia R, Pardo M, Carreira MC, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014; 63(4): 520-31, CrossRef.
Huerta AE, Prieto-Hontoria PL, Fernández-Galilea M, Sáinz N, Cuervo M, Martínez JA, et al. Circulating irisin and glucose metabolism in overweight/obese women: Effects of α-lipoic acid and eicosapentaenoic acid. J Physiol Biochem. 2015; 71(3): 547-58, CrossRef.
Mazur-Bialy AI, Bilski J, Pochec E, Brzozowski T. New insight into the direct anti-inflammatory activity of a myokine irisin against proinflammatory activation of adipocytes. Implication for exercise in obesity. J Physiol Pharmacol. 2017; 68(2): 243-51, PMID .
Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, Garcia-Escobar E, Haro-Mora JJ, Garcia-Arnes J, et al. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest. 2014; 44(10): 918-25, CrossRef.
Choi CHJ, Cohen P. Adipose crosstalk with other cell types in health and disease. Exp Cell Res. 2017; 360(1): 6-11, CrossRef.
Hou N, Liu Y, Han F, Wang D, Hou X, Hou S, et al. Irisin improves perivascular adipose tissue dysfunction via regulation of the heme oxygenase-1/adiponectin axis in diet-induced obese mice. J Mol Cell Cardiol. 2016; 99: 188-96, CrossRef.
Han F, Zhang S, Hou N, Wang D, Sun X. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. Am J Physiol Heart Circ Physiol. 2015; 309(9): H1501-8, CrossRef.
Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease. Nat Commun. 2021; 12(1): 330, CrossRef.
Fuchs E, Blau HM. Tissue stem cells: Architects of their niches. Cell Stem Cell. 2020; 27(4): 532-56, CrossRef.
Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 1961; 9(2): 493-5, CrossRef.
Hernandez-Hernandez R. SSA 04-2 Obesity the most influencing and modifiable risk factors in Latin America. J Hypertens. 2016; 34(Suppl 1): e6, CrossRef.
Yin H, Price F, Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev. 2013; 93(1): 23-67, CrossRef.
Evano B, Gill D, Hernando-Herraez I, Comai G, Stubbs TM, Commere PH, et al. Transcriptome and epigenome diversity and plasticity of muscle stem cells following transplantation. PLoS Genet. 2020; 16(10): e1009022, CrossRef.
Carrero-Rojas G, Benítez-Temiño B, Pastor AM, Davis López de Carrizosa MA. Muscle progenitors derived from extraocular muscles express higher levels of neurotrophins and their receptors than other cranial and limb muscles. Cells. 2020; 9(3): 747, CrossRef.
Zhang H, Ryu D, Wu Y, Gariani K, Wang X, Luan P, et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016; 352(6292): 1436-43, CrossRef.
Brack AS, Bildsoe H, Hughes SM. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J Cell Sci. 2005; 118(Pt 20): 4813-21, CrossRef.
García-Prat L, Perdiguero E, Alonso-Martín S, Dell’Orso S, Ravichandran S, Brooks SR, et al. FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age. Nat Cell Biol. 2020; 22(11): 1307-18, CrossRef.
Cornish SM, Bugera EM, Duhamel TA, Peeler JD, Anderson JE. A focused review of myokines as a potential contributor to muscle hypertrophy from resistance-based exercise. Eur J Appl Physiol. 2020; 120(5): 941-59, CrossRef.
Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: A renaissance in metabolism? Metabolism. 2013; 62(8): 1037-44, CrossRef.
Villarroya F. Irisin, turning up the heat. Cell Metab. 2012; 15(3): 277-8, CrossRef.
Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, et al. Physiology of activins/follistatins: Associations with metabolic and anthropometric variables and response to exercise. J Clin Endocrinol Metab. 2018; 103(10): 3890-9, CrossRef.
Zhang J, Valverde P, Zhu X, Murray D, Wu Y, Yu L, et al. Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism. Bone Res. 2017; 5: 16056, CrossRef.
Butt ZD, Hackett JD, Volkoff H. Irisin in goldfish (Carassius auratus): Effects of irisin injections on feeding behavior and expression of appetite regulators, uncoupling proteins and lipoprotein lipase, and fasting-induced changes in FNDC5 expression. Peptides. 2017; 90: 27-36, CrossRef.
Sundarrajan L, Yeung C, Hahn L, Weber LP, Unniappan S. Irisin regulates cardiac physiology in zebrafish. PLoS One. 2017; 12(8): e0181461, CrossRef.
Schlögl M, Piaggi P, Votruba SB, Walter M, Krakoff J, Thearle MS. Increased 24-hour ad libitum food intake is associated with lower plasma irisin concentrations the following morning in adult humans. Appetite. 2015; 90: 154-9, CrossRef.
Huang J, Wang S, Xu F, Wang D, Yin H, Lai Q, et al. Exercise training with dietary restriction enhances circulating irisin level associated with increasing endothelial progenitor cell number in obese adults: An intervention study. PeerJ. 2017; 5: e3669, CrossRef.
Palacios-González B, Vadillo-Ortega F, Polo-Oteyza E, Sánchez T, Ancira-Moreno M, Romero-Hidalgo S, et al. Irisin levels before and after physical activity among school-age children with different BMI: A direct relation with leptin. Obesity. 2015; 23(4): 729-32, CrossRef.
Crujeiras AB, Zulet MA, Lopez-Legarrea P, De La Iglesia R, Pardo M, Carreira MC, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014; 63(4): 520-31, CrossRef.
García-Fontana B, Reyes-García R, Morales-Santana S, Ávila-Rubio V, Muñoz-Garach A, Rozas-Moreno P, et al. Relationship between myostatin and irisin in type 2 diabetes mellitus: A compensatory mechanism to an unfavourable metabolic state? Endocrine. 2016; 52(1): 54-62, CrossRef.
Al-Daghri NM, Mohammed AK, Al-Attas OS, Amer OE, Clerici M, Alenad A, et al. SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects. Lipids Health Dis. 2016; 15: 54, CrossRef.
Liu JJ, Liu S, Wong MDS, Tan CSH, Tavintharan S, Sum CF, et al. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications. 2014; 28(2): 208-13, CrossRef.
Li X, Lindholm B. The role of irisin in kidney diseases. Clinica Chimica Acta. 2024; 554: 117756, CrossRef.
Shelbaya S, Abu Shady MM, Nasr MS, Bekhet MM, Mageed YAA, Abbas M. Study of irisin hormone level in type 2 diabetic patients and patients with diabetic nephropathy. Curr Diabetes Rev. 2018; 14(5): 481-6, CrossRef.
Li DJ, Huang F, Lu WJ, Jiang GJ, Deng YP, Shen FM. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. Acta Physiologica. 2015; 213(3): 711-21, CrossRef.
Pang Y, Zhu H, Xu J, Yang L, Liu L, Li J. β-arrestin-2 is involved in irisin induced glucose metabolism in type 2 diabetes via p38 MAPK signaling. Exp Cell Res. 2017; 360(2): 199-204, CrossRef.
Mo L, Shen J, Liu Q, Zhang Y, Kuang J, Pu S, et al. Irisin is regulated by CAR in liver and is a mediator of hepatic glucose and lipid metabolism. Mol Endocrinol. 2016; 30(5): 533-42, CrossRef.
Park MJ, Kim DI, Choi JH, Heo YR, Park SH. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro. Cell Signal. 2015; 27(9): 1831-9, CrossRef.
Tang H, Yu R, Liu S, Huwatibieke B, Li Z, Zhang W. Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2 signaling. EBioMedicine. 2016; 6: 139-48, CrossRef.
So WY, Leung PS. Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling. Int J Biochem Cell Biol. 2016; 78: 237-47, CrossRef.
Aydin S, Aydin S, Ogeturk M, Kuloglu T, Kavakli A. Effect of carnosine supplementation on apoptosis and irisin, total oxidant and antioxidants levels in the serum, liver and lung tissues in rats exposed to formaldehyde inhalation. Peptides. 2015; 64: 14-23, CrossRef.
Polyzos S, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: The pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009; 9(3): 299-314, CrossRef.
Hou N, Han F, Sun X. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol. 2015; 83(3): 339-43, CrossRef.
Xie C, Zhang Y, Tran TDN, Wang H, Li S, George EV, et al. Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts. PLoS One. 2015; 10(8): e0136816, CrossRef.
Polyzos SA, Goulis DG, Kountouras J, Mintziori G, Chatzis P, Papadakis E, et al. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Assessment of non-invasive indices predicting hepatic steatosis and fibrosis. Hormones. 2014; 13(4): 519-31, CrossRef.
Gao S, Cheng Y, Zhao L, Chen Y, Liu Y. The relationships of irisin with bone mineral density and body composition in PCOS patients. Diabetes Metab Res Rev. 2016; 32(4): 421-8, CrossRef.
Arhire LI, Mihalache L, Covasa M. Irisin: A hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol. 2019: 10: 524, CrossRef.
Colaianni G, Cuscito C, Mongelli T, Oranger A, Mori G, Brunetti G, et al. Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol. 2014: 2014: 902186, CrossRef.
Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Makras P, Perakakis N, Kountouras J, et al. Irisin in metabolic diseases. Endocrine. 2018; 59(2): 260-74, CrossRef.
Chandra A, Rajawat J. Skeletal aging and osteoporosis: Mechanisms and therapeutics. Int J Mol Sci. 2021; 22(7): 3553, CrossRef.
Kaji H. Effects of myokines on bone. Bonekey Rep. 2016: 5: 826, CrossRef.
Colaianni G, Mongelli T, Cuscito C, Pignataro P, Lippo L, Spiro G, et al. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice. Sci Rep. 2017; 7(1): 2811, CrossRef.
Anastasilakis AD, Polyzos SA, Makras P, Gkiomisi A, Bisbinas I, Katsarou A, et al. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months. Osteoporos Int. 2014; 25(5): 1633-42, CrossRef.
Singh L, Brennan TA, Russell E, Kim JH, Chen Q, Brad Johnson F, et al. Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage. Bone. 2016; 85: 29-36, CrossRef.
Duncan EL. Gene testing in everyday clinical use: Lessons from the bone clinic. J Endocr Soc. 2020; 5(4): bvaa200, CrossRef.
Patsch JM, Kohler T, Berzlanovich A, Muschitz C, Bieglmayr C, Roschger P, et al. Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis. J Bone Miner Res. 2011; 26(7): 1584-92, CrossRef.
Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008; 283(9): 5866-75, CrossRef.
Klangjareonchai T, Nimitphong H, Saetung S, Bhirommuang N, Samittarucksa R, Chanprasertyothin S, et al. Circulating sclerostin and irisin are related and interact with gender to influence adiposity in adults with prediabetes. Int J Endocrinol. 2014; 2014: 261545, CrossRef.
Tsourdi E, Jähn K, Rauner M, Busse B, Bonewald LF. Physiological and pathological osteocytic osteolysis. J Musculoskelet Neuronal Interact. 2018; 18(3): 292-303, PMID.
Colaianni G, Sanesi L, Storlino G, Brunetti G, Colucci S, Grano M. Irisin and bone: From preclinical studies to the evaluation of its circulating levels in different populations of human subjects. Cells. 2019; 8(5): 451, CrossRef.
Anastasilakis AD, Polyzos SA, Makras P, Douni E, Mantzoros CS. Irisin: Good or bad for the bone? A new path forward after the reported discovery of irisin receptor? Metabolism. 2019; 93: 100-2, CrossRef.
Amaro-Gahete FJ, De-la-O A, Jurado-Fasoli L, Sanchez-Delgado G, Ruiz JR, Castillo MJ. Metabolic rate in sedentary adults, following different exercise training interventions: The FIT-AGEING randomized controlled trial. Clin Nutr. 2020; 39(11): 3230-40, CrossRef.
Barha CK, Davis JC, Falck RS, Nagamatsu LS, Liu-Ambrose T. Sex differences in exercise efficacy to improve cognition: A systematic review and meta-analysis of randomized controlled trials in older humans. Front Neuroendocrinol. 2017; 46: 71-85, CrossRef.
Singh AS, Saliasi E, Van Den Berg V, Uijtdewilligen L, De Groot RHM, Jolles J, et al. Effects of physical activity interventions on cognitive and academic performance in children and adolescents: A novel combination of a systematic review and recommendations from an expert panel. Br J Sports Med. 2019; 53(10): 640-7, CrossRef.
Rabin LA, Smart CM, Amariglio RE. Subjective cognitive decline in preclinical Alzheimer’s disease. Annu Rev Clin Psychol. 2017; 13: 369-96, CrossRef.
Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017; 13(4): 217-31, CrossRef.
Xu M, Zhu J, Liu XD, Luo MY, Xu NJ. Roles of physical exercise in neurodegeneration: Reversal of epigenetic clock. Transl Neurodegener. 2021; 10(1): 30, CrossRef.
Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. 2004; 20(10): 2580-90, CrossRef.
Vaynman SS, Ying Z, Yin D, Gomez-Pinilla F. Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res. 2006; 1070(1): 124-30, CrossRef.
Ruan Q, Zhang L, Ruan J, Zhang X, Chen J, Ma C, et al. Detection and quantitation of irisin in human cerebrospinal fluid by tandem mass spectrometry. Peptides. 2018; 103: 60-4, CrossRef.
Ahmadi Ghahrizjani F, Ghaedi K, Salamian A, Tanhaei S, Shoaraye Nejati A, Salehi H, et al. Enhanced expression of FNDC5 in human embryonic stem cell-derived neural cells along with relevant embryonic neural tissues. Gene. 2015; 557(2): 123-9, CrossRef.
Peng J, Wu J. Effects of the FNDC5/irisin on elderly dementia and cognitive impairment. Front Aging Neurosci. 2022; 14: 863901, CrossRef.
Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019; 15(10): 565-81, CrossRef.
Singh T, Yadav S. Role of microRNAs in neurodegeneration induced by environmental neurotoxicants and aging. Ageing Res Rev. 2020; 60: 101068, CrossRef.
Corrochano S, Blanco G, Acevedo-Arozena A. Skeletal muscle modulates Huntington’s disease pathogenesis in mice: Role of physical exercise. J Exp Neurosci. 2018; 12: 1179069518809059, CrossRef.
Michalski B, Fahnestock M. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s disease. Brain Res Mol Brain Res. 2003; 111(1-2): 148-54, CrossRef.
Arancibia S, Silhol M, Moulière F, Meffre J, Höllinger I, Maurice T, et al. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis. 2008; 31(3): 316-26, CrossRef.
Giampà C, Montagna E, Dato C, Melone MAB, Bernardi G, Fusco FR. Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington’s disease. PLoS One. 2013; 8(5): e64037, CrossRef.
Küster OC, Laptinskaya D, Fissler P, Schnack C, Zügel M, Nold V, et al. Novel blood-based biomarkers of cognition, stress, and physical or cognitive training in older adults at risk of dementia: Preliminary evidence for a role of BDNF, irisin, and the kynurenine pathway. J Alzheimers Dis. 2017; 59(3): 1097-111, CrossRef.
Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med. 2019; 25(1): 165-75, CrossRef.
Young MF, Valaris S, Wrann CD. A role for FNDC5/irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases. Prog Cardiovasc Dis. 2019; 62(2): 172-8, CrossRef.
Priest C, Tontonoz P. Inter-organ cross-talk in metabolic syndrome. Nat Metab. 2019; 1(12): 1177-88, CrossRef.
Weigert C, Hoene M, Plomgaard P. Hepatokines—A novel group of exercise factors. Pflugers Arch. 2019; 471(3): 383-96, CrossRef.
Meex RCR, Watt MJ. Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017; 13(9): 509-20, CrossRef.
Mera P, Ferron M, Mosialou I. Regulation of energy metabolism by bone-derived hormones. Cold Spring Harb Perspect Med. 2018; 8(6): a031666, CrossRef.
Kanaley JA, Weltman JY, Pieper KS, Weltman A, Hartman ML. Cortisol and growth hormone responses to exercise at different times of day. J Clin Endocrinol Metab. 2001; 86(6): 2881-9, CrossRef.
Lundsgaard AM, Fritzen AM, Kiens B. The importance of fatty acids as nutrients during post-exercise recovery. Nutrients. 2020; 12(2): 280, CrossRef.
DoctorLib [Internet]. Medical Physiology A Cellular and Molecular Approach. 2nd Ed.: Exercise Physiology and Sport Science [cited 2023 May 12]. Available from: https://doctorlib.info/.
Yu Q, Kou W, Xu X, Zhou S, Luan P, Xu X, et al. FNDC5/irisin inhibits pathological cardiac hypertrophy. Clin Sci. 2019; 133(5): 611-27, CrossRef.
Ye W, Wang J, Lin D, Ding Z. The immunomodulatory role of irisin on osteogenesis via AMPK-mediated macrophage polarization. Int J Biol Macromol. 2020; 146: 25-35, CrossRef.
Fischer CP. Interleukin-6 in acute exercise and training: What is the biological relevance? Exerc Immunol Rev. 2006; 12: 6-33, PMID.
Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argués JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009; 296(1): 191-202, CrossRef.
Li ZY, Song J, Zheng SL, Fan MB, Guan YF, Qu Y, et al. Adipocyte METRNL antagonizes insulin resistance through PPARγ signaling. Diabetes. 2015; 64(12): 4011-22, CrossRef.
Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014; 157(6): 1279-91, CrossRef.
Jung TW, Lee SH, Kim HC, Bang JS, Abd El-Aty AM, Hacımüftüoğlu A, et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice. Exp Mol Med. 2018; 50(9): 1-11, CrossRef.
Alkhairi I, Cherian P, Abu-Farha M, Al Madhoun A, Nizam R, Melhem M, et al. Increased expression of meteorin-like hormone in type 2 diabetes and obesity and its association with irisin. Cells. 2019; 8(10): 1283, CrossRef.
Park BS, Tu TH, Lee H, Jeong DY, Yang S, Lee BJ, et al. Beta-aminoisobutyric acid inhibits hypothalamic inflammation by reversing microglia activation. Cells. 2019; 8(12): 1609, CrossRef.
Tanianskii DA, Jarzebska N, Birkenfeld AL, O’sullivan JF, Rodionov RN. Beta-aminoisobutyric acid as a novel regulator of carbohydrate and lipid metabolism. Nutrients. 2019; 11(3): 524. doi: 10.3390/ nu11030524, CrossRef.
Jung TW, Hwang HJ, Hong HC, Yoo HJ, Baik SH, Choi KM. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK–PPARδ-dependent pathway in mice. Diabetologia. 2015; 58(9): 2096-105, CrossRef.
Allen DL, Hittel DS, McPherron AC. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc. 2011; 43(10): 1828-35, CrossRef.
Zhang C, McFarlane C, Lokireddy S, Masuda S, Ge X, Gluckman PD, et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia. 2012; 55(1): 183-93, CrossRef.
Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J. 2013; 27(5): 1981-9, CrossRef.
Sargeant JA, Aithal GP, Takamura T, Misu H, Takayama H, Douglas JA, et al. The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men. Appl Physiol Nutr Metab. 2018; 43(5): 482-90, CrossRef.
Misu H, Takayama H, Saito Y, Mita Y, Kikuchi A, Ishii KA, et al. Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle. Nat Med. 2017; 23(4): 508-16, CrossRef.
Choi HY, Hwang SY, Lee CH, Hong HC, Yang SJ, Yoo HJ, et al. Increased selenoprotein P levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J. 2013; 37(1): 63-71, CrossRef.
Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008; 57(10): 2762-7, CrossRef.
Ramírez-Vélez R, García-Hermoso A, Hackney AC, Izquierdo M. Effects of exercise training on fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: A systematic review and meta-analysis. Lipids Health Dis. 2019; 18: 23, CrossRef.
Von Holstein-Rathlou S, Bondurant LD, Peltekian L, Naber MC, Yin TC, Claflin KE, et al. FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver. Cell Metab. 2016; 23(2): 335-43, CrossRef.
Mattijssen F, Alex S, Swarts HJ, Groen AK, van Schothorst EM, Kersten S. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Mol Metab. 2013; 3(2): 135-44, CrossRef.
Janssen AWF, Katiraei S, Bartosinska B, Eberhard D, Willems van Dijk K, Kersten S. Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota. Diabetologia. 2018; 61(6): 1447-58, CrossRef.
Hansen JS, Plomgaard P. Circulating follistatin in relation to energy metabolism. Mol Cell Endocrinol. 2016; 433: 87-93, CrossRef.
Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, et al. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol. 2004; 270(1): 19-30, CrossRef.
Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab. 2009; 297(1): E157-64, CrossRef.
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3): 456-69, CrossRef.
Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012; 50(2): 568-75, CrossRef.
Gonzalez-Gil AM, Elizondo-Montemayor L. The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients. 2020; 12(6): 1899, CrossRef.
Bouassida A, Chamari K, Zaouali M, Feki Y, Zbidi A, Tabka Z. Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med. 2010; 44(9): 620-30, CrossRef.
Görgens SW, Eckardt K, Jensen J, Drevon CA, Eckel J. Exercise and regulation of adipokine and myokine production. Prog Mol Biol Transl Sci. 2015; 135: 313-36, CrossRef.
Becic T, Studenik C, Hoffmann G. Exercise increases adiponectin and reduces leptin levels in prediabetic and diabetic individuals: Systematic review and meta-analysis of randomized controlled trials. Med Sci. 2018; 6(4): 97, CrossRef.
Magkos F, Mohammed BS, Patterson BW, Mittendorfer B. Free fatty acid kinetics in the late phase of postexercise recovery: Importance of resting fatty acid metabolism and exercise-induced energy deficit. Metabolism. 2009; 58(9): 1248-55, CrossRef.
Sabek OM, Nishimoto SK, Fraga D, Tejpal N, Ricordi C, Gaber AO. Osteocalcin effect on human β-cells mass and function. Endocrinology. 2015; 156(9): 3137-46, CrossRef.
Stone T, DiPietro L, Stachenfeld NS. Exercise treatment of obesity. In: Feingold KR, Anawalt B, Blackman MR, editors. Endotext. South Dartmouth (MA): MDText.com.; 2000, PMID .
Petridou A, Siopi A, Mougios V. Exercise in the management of obesity. Metabolism. 2019; 92: 163-9, CrossRef.
Rana KS, Arif M, Hill EJ, Aldred S, Nagel DA, Nevill A, et al. Plasma irisin levels predict telomere length in healthy adults. Age. 2014; 36(2): 995-1001, CrossRef.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121): 860-7, CrossRef.
Liu S, Du F, Li X, Wang M, Duan R, Zhang J, et al. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells. PLoS One. 2017; 12(4): e0175498, CrossRef.
Rezaee MRS, Amiri AA, Hashemi-Soteh MB, Daneshvar F, Emady-Jamaly R, Jafari R, et al. Aldose reductase C-106T gene polymorphism in type 2 diabetics with microangiopathy in Iranian individuals. Indian J Endocrinol Metab. 2015; 19(1): 95-9, CrossRef.
Shanaki M, Moradi N, Emamgholipour S, Fadaei R, Poustchi H. Lower circulating irisin is associated with nonalcoholic fatty liver disease and type 2 diabetes. Diabetes Metab Syndr. 2017: 11(Suppl 1): S467-72, CrossRef.
Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, et al. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res. 2005; 36(4): 376-81, CrossRef.
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107(9): 1058-70, CrossRef.
Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005; 59(7): 365-73, CrossRef.
Amirkabirian N, Teimouri F, Esmaily H, Mohammadirad A, Aliahmadi A, Abdollahi M. Protection by pentoxifylline of diazinon-induced toxic stress in rat liver and muscle. Toxicol Mech Methods. 2007; 17(4): 215-21, CrossRef.
Cichoz-Lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014; 20(25): 8082-91, CrossRef.
Pedersen BK, Febbraio MA. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012; 8(8): 457-65, CrossRef.
Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res. 2011; 317(5): 664-73, CrossRef.
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010; 49(11): 1603-16, CrossRef.
Zhang Y, Wang L, Kang H, Lin CY, Fan Y. Unlocking the therapeutic potential of irisin: Harnessing its function in degenerative disorders and tissue regeneration. Int J Mol Sci. 2023; 24(7): 6551, CrossRef.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell. 2006; 127(6): 1109-22, CrossRef.
Chang JS, Kim TH, Nguyen TT, Park KS, Kim N, Kong ID. Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study. Geriatr Gerontol Int. 2017; 17(11): 2266-73, CrossRef.
Zerlotin R, Oranger A, Pignataro P, Dicarlo M, Maselli F, Mori G, et al. Irisin and secondary osteoporosis in humans. Int J Mol Sci. 2022; 23(2): 690, CrossRef.
Hillman CH, Erickson KI, Kramer AF. Be smart, exercise your heart: Exercise effects on brain and cognition. Nat Rev Neurosci. 2008; 9(1): 58-65, CrossRef.
Gubert C, Hannan AJ. Exercise mimetics: Harnessing the therapeutic effects of physical activity. Nat Rev Drug Discov. 2021; 20(11): 862-79, CrossRef.
Liu Y, Xu F, Jiang P. Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α and irisin in a rat model of type 2 diabetes mellitus. J Int Med Res. 2020; 48(5): 300060519885569, CrossRef.
Amengual J, García-Carrizo FJ, Arreguín A, Mušinović H, Granados N, Palou A, et al. Retinoic acid increases fatty acid oxidation and irisin expression in skeletal muscle cells and impacts irisin in vivo. Cell Physiol Biochem. 2018; 46(1): 187-202, CrossRef.
Ko BJ, Park KH, Shin S, Zaichenko L, Davis CR, Crowell JA, et al. Diet quality and diet patterns in relation to circulating cardiometabolic biomarkers. Clin Nutr. 2016; 35(2): 484-90, CrossRef.
Chen SQ, Ding LN, Zeng NX, Liu HM, Zheng SH, Xu JW, et al. Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway. Biomed Pharmacother. 2019; 115: 108930, CrossRef.
Heredia-Lugo V, Garcia-Tobilla P, Rodriguez M, Palacios B. Effect of resveratrol in methylation promoter of FNDC5 gene in skeletal muscle and adipose tissue. FASEB J. 2018; 31: 646.55, CrossRef.
de Souza Rocha G, da Silva Ferreira R, da Matta Alvarez Pimenta N, Monteiro da Fonseca L, Mafra D, Blondet V, et al. Effects of resveratrol, grape juice or red wine consumption Irisin levels and fibronectin type III domain containing protein 5 and uncoupoling protein gene expression modulation in rats. Clin Nutr Exp. 2016; 5: 1-5, CrossRef.
Xiong H, Wang J, Ran Q, Lou G, Peng C, Gan Q, et al. Hesperidin: A therapeutic agent for obesity. Drug Des Devel Ther. 2019; 13: 3855-66, CrossRef.
Kamio N, Suzuki T, Watanabe Y, Suhara Y, Osakabe N. A single oral dose of flavan-3-ols enhances energy expenditure by sympathetic nerve stimulation in mice. Free Radic Biol Med. 2016; 91: 256-63, CrossRef.
Choo JJ. Green tea reduces body fat accretion caused by high-fat diet in rats through β-adrenoceptor activation of thermogenesis in brown adipose tissue. J Nutr Biochem. 2003; 14(11): 671-6, CrossRef.
Yoneshiro T, Aita S, Matsushita M, Kayahara T, Kameya T, Kawai Y, et al. Recruited brown adipose tissue as an antiobesity agent in humans. J Clin Invest. 2013; 123(8): 3404-8, CrossRef.
Ludy MJ, Moore GE, Mattes RD. The effects of capsaicin and capsiate on energy balance: Critical review and meta-analyses of studies in humans. Chem Senses. 2012; 37(2): 103-21, CrossRef.
Kim SW, Choi JH, Mukherjee R, Hwang KC, Yun JW. Proteomic identification of fat-browning markers in cultured white adipocytes treated with curcumin. Mol Cell Biochem. 2016; 415(1-2): 51-66, CrossRef.
Silvester AJ, Aseer KR, Yun JW. Dietary polyphenols and their roles in fat browning. J Nutr Biochem. 2019; 64: 1-12, CrossRef.
Lee SG, Parks JS, Kang HW. Quercetin, a functional compound of onion peel, remodels white adipocytes to brown-like adipocytes. J Nutr Biochem. 2017; 42: 62-71, CrossRef.
Zhang Z, Zhang H, Li B, Meng X, Wang J, Zhang Y, et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun. 2014; 5: 5493, CrossRef.
DOI: https://doi.org/10.18585/inabj.v16i2.2996
Copyright (c) 2024 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
